Adult RBCs have previously been considered negative for CD36. However, using fluorescence-activated cell sorter analysis with the antLCD36 MoAbs 8A6,OKM5, and OKM8, which reverse rosetting, we consistently detect CD36 on the majority of normal adult RBCs. Absorption of the MoAb solutions with CD36-transfected Chinese hamster ovary (CHO-CD36) cells removed the reactivity against both CHO-CD36 cells and RBCs, whereas absorption with CHO cells had no effect. By D36 IS AN 88-Kd gly~oproteinl-~ expressed at high C levels on platelets,' monocytes,' and some types of endothelial CD36 appears to be a receptor for thrombospondin (TSP),7 because purified CD36338 and CD36 expressed on activated platelet^^,^ and some tumor cell^^,^ can bind TSP. However, CD36 may vary in its TSP-binding activity, because resting platelets express 1,000 molecules of TSP/cell and activated platelets 16,000/ cell,loJ1 even though CD36 is present on resting and activated platelets in similar amounts (12,000 molecules/ ce11).12 Platelets and monocytes can be activated by anti-CD36 antibodies, suggesting that CD36 may have a signal transduction role in these cell^.^^-'^ CD36 and TSP appear to be involved in several cell adhesion processes, including thrombin-induced platelet aggregation,1°J2J6J7 adhesion of platelets to monocytes,1s and tumor cell attachment to the extracellular matrk9 CD36 has also been shown to act as a collagen receptor in collagen-induced platelet aggregation.19 Nevertheless, the physiologic role of CD36 is not clear because 3% to 11% of Japanese individuals have been shown to be lacking CD36 expression on platelets, with no apparent adverse consequences for health20 or for TSP binding by these platelets.21 CD36 is also thought to play a major role in infection with Plasmodium falciparum malaria. Most patient isolates of P fakipalum have the capacity to adhere to CD36.22,23 Adherence of infected cells to CD36 on endothelial cells24 is thought to contribute to the sequestration of mature infected cells in the microvasculature, thus preventing their destruction in the ~pleen.~5 Adherence of infected cells to CD36 on monocytes activates these monocytes15 and thus may contribute to the immunopathology of 1nalaria.*6,~~ We now provide evidence for the expression of low levels of CD36 antigen on the surface of red blood cells (RBCs) in normal human blood. CD36 has not been detected previously on adult erythrocyte^,^^-^^ although it is expressed on cells at an earlier stage of erythroid de~elopment.~8J~ The expression of CD36 on erythrocytes appears to be physiologically significant in infection with P falciparum malaria, because we have recently shown that CD36 acts as a receptor for rosetting of P fakiparum-infected erythrocytes with uninfected RBC. 
CD36 antibodies, suggesting that CD36 may have a signal transduction role in these cell^.^^-'^ CD36 and TSP appear to be involved in several cell adhesion processes, including thrombin-induced platelet aggregation,1°J2J6J7 adhesion of platelets to monocytes,1s and tumor cell attachment to the extracellular matrk9 CD36 has also been shown to act as a collagen receptor in collagen-induced platelet aggregation.19 Nevertheless, the physiologic role of CD36 is not clear because 3% to 11% of Japanese individuals have been shown to be lacking CD36 expression on platelets, with no apparent adverse consequences for health20 or for TSP binding by these platelets.21 CD36 is also thought to play a major role in infection with Plasmodium falciparum malaria. Most patient isolates of P fakipalum have the capacity to adhere to CD36.22,23 Adherence of infected cells to CD36 on endothelial cells24 is thought to contribute to the sequestration of mature infected cells in the microvasculature, thus preventing their destruction in the ~pleen.~5 Adherence of infected cells to CD36 on monocytes activates these monocytes15 and thus may contribute to the immunopathology of 1nalaria.*6,~~
We now provide evidence for the expression of low levels of CD36 antigen on the surface of red blood cells (RBCs) in normal human blood. CD36 has not been detected previously on adult erythrocyte^,^^-^^ although it is expressed on cells at an earlier stage of erythroid de~elopment.~8J~ The expression of CD36 on erythrocytes appears to be physiologically significant in infection with P falciparum malaria, because we have recently shown that CD36 acts as a receptor for rosetting of P fakiparum-infected erythrocytes with uninfected RBC. 31508). Stain 4 was a Rb anti-Mu IgG Fc (Jackson; 315-005-046) followed by FITC-Go anti-Rb IgG (whole molecule) (Sigma; no. F0382). Stain 5 was a R-phycoerythrin (R-PE)-labeled Go anti-Mu IgG (whole molecule) (Sigma; no. P9287). Stain 6 was a R-PE F(ab')z of Go anti-Mu IgG Fc (Jackson; 115-116-071). Stain 7 was an R-PE Go anti-Mu IgGl (Caltag Labs, South San Francisco, CA; no. M32004). Stain 8 was an Rb anti-MuIgG Fc (Jackson; 315-005-046) followed by R-PE F(ab')z of Go anti-RbIgG (H + L) (Caltag Labs; no. L43004).
O+ RBCs obtained from healthy adult donors who had tested negative for hepatitis B and human immunodeficiency virus (HIV) antibody were passed through an RC50 transfusion grade leukocyte removal filter (Pall Biomedical Products Co, East Hills, NY). The absence of leukocytes was established by light microscopy of Giemsa-stained blood films and by forward and side scatter in FACS analysis. RBCs from six different O+ donors were tested. The P falcipamm isolate from Gambian patient 425 (GAM425) was collected in 1985 from a patient reporting to the clinic of the Medical Research Laboratories (Fajara, The Gambia) and the rosetting properties of this sample of parasites have been described e l s e~h e r e . *~.~~~ Cryopreserved GAM425 RBCs (blood group 0) containing 15% ring-stage Pfulcipamm-infected RBCs were thawed in parallel with a cryopreserved sample of normal Of RBCs, washed, and allowed to equilibrate in RPMI at 4°C for 24 hours before staining and analysis. Freshly outdated platelets were obtained from Peninsula Blood Bank (San Mateo, CA). Stable transfectants of Chinese hamster ovary (CHO) cells bearing CD36 were derived in this laboratory34a and are denoted CHO-CD36. CHO cells, CHO-CD36 cells, C32 human malignant melanoma cells (ATCC no. CRL1585), and U937 myelomonocytic cells (ATCC no. CRL1593) were grown in RPMI 1640 containing 10% fetal calf serum (FCS), 100 U/mL penicillin, and 100 pg/mL streptomycin (all media from JRH Biosciences, Lenexa, KS).
Fifty-microliter amounts of leukocyte-depleted, washed O+ RBCs at 0.2% hematocrit (Hct) in phosphate-buffered saline (PBS) containing 2 mmol/L EDTA and 1 mg/mL bovine serum albumin (BSA, Sigma globulin-free grade, no. A7638) (PBS/BSAl) were aliquotted into V-shaped 96-well plates (Costar Serocluster plate no. 3898; Costar, Cambridge, Cells.
CeN staining for FACS analysis. MA). Platelets were washed in PBS/BSAl and aliquotted into Eppendorf tubes at lo6 per tube. Fifty-microliter aliquots of 10 pg/mL solutions of MoAbs in PBS/BSAl were added and incubated on ice for 1 hour. Antiglycophorin MoAbs were used as a 1/1,000 dilution of hybridoma supernatant to minimize agglutination. Other hybridoma supernatants were used undiluted as 50-pL aliquots, after the addition of 2 mmol/L EDTA and 25 mmol/L HEPES, pH 7.4. RBCs were washed by centrifuging plates for 5 minutes at l,OOOg, flicking the plates, and resuspending cells in PBS/BSAl for each wash. Platelets were washed by microfuging at 7,000g for 1 minute and aspirating the supernatant. After two washes with 200 pL PBS/BSAl, cells were resuspended in 50 pL 1/50 dilution of secondary antibody and incubated on ice 45 minutes. For tertiary staining, washing and incubation were repeated with the tertiary antibody. By contrast, data with 10F7MN were purposely obtained with concentrations of hybridoma supernatant far below saturating, because at higher levels of antibody the fluorescence of the cells was offscale on the instrument. Under the conditions used with 10F7MN, the presence of agglutinates was not significant during FACS analysis, as seen from forward and side scatter.
Absorption of 8A6 and OKM5 MoAbs with cells bearing CD36. CHO-CD36 cells and untransfected CHO cells were grown to near-confluency. Cells were detached with PBS containing 2 mmol/L EDTA, washed with PBS containing 2% FCS and 2 mmol/L EDTA (PBS/FCS), and kept on ice during all subsequent operations. To lo7 CHO-CD36 or CHO cells, or to lo9 RBCs, 0.4 mL of a 5 pg/mL MoAb dilution in PBS/FCS was added and the suspensions left on ice for 45 minutes with occasional mixing. Cells were centrifuged at 2,00Og for 5 minutes and the supernatants were removed (supernatant no. 1). The absorption was repeated twice by adding part of the supernatant successively to two fresh aliquots of cells, yielding supernatants no. 2 and 3. All supernatants were microfuged at 15,OOOg for 5 minutes to remove any particulate material before FACS staining. FACS staining was performed as
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From CD36 ON ERYTHROCYTES 2107 described for RBCs above, except that PBS/FCS was used as the diluent buffer, 100 p,L MoAb dilution was used per well, and cells stained included also CHO or CHO-CD36 at 2 X l@ cells per well. Stain 6 (see Antibodies) was used as the secondary reagent. In parallel, CHO-CD36 cells and RBCs were stained with a series of doubling dilutions of the original 5 pg/mL solution of MoAb, so that the extent of absorption at each step could be determined by comparison with this standard titration. Mean fluorescence was used as the titration parameter with different concentrations of MoAb. With RBCs the percentage of positive cells (as defined by subtraction of the control with secondary reagent alone) could also be used to monitor the titration.
Tenmicroliter aliquots of 10 kg/mL dilutions of MoAbs, 10 pg/mL dilutions of affinity-purified Rb anti-MuIgG (Fc specific, Hu serum absorbed; Jackson Immunoresearch Labs; cat. no. 315-005-046), or 50 Fg/mL dilutions of protein A (Pharmacia-LKB, Piscataway, NJ) in PBS were spotted onto bacteriologic petri dishes (Falcon Optilux no. 1005) inside larger wells demarcated with adherent parafilm." In the case of the protein A spots, all PBS solutions used in the assay were adjusted to pH 8 to enhance binding of IgGl MoAbs. After standing at RT for 1 hour, the spots were aspirated and immediately overlaid with 50 p L PBS containing 10 mg/mL BSA (Sigma globulin-free grade, no. A7638) (PBS/BSAlO). The wells were aspirated again and overlaid with PBS/BSA10, then left at RT for 1 hour to block protein binding sites on the plastic. The wells were then washed three times with 50 kL PBS/BSA10. In the case of protein A or Rb anti-MuIgG spots, 30 kL of 10 pg/mL dilutions of MoAbs or twofold dilutions of hybridoma supernatants were added to the wells, incubated for 1 hour at RT, and washed five times with PBS/BSA10. The wells were then overlaid with 50 pL of a 1% Hct suspension of leukocyte-depleted normal O+ RBCs freshly washed with PBS/BSA10, and incubated at 37°C for 45 minutes. The parafilm was carefully removed and 10 mL PBS/BSA10 carefully dripped over the entire plate without disturbing the spots. After blocking for 30 minutes at RT, nonadherent cells were resuspended by careful swirling and aspiration and the plates washed in this manner one further time with PBS/BSA10 and twice with PBS. Ten milliliters of 2% glutaraldehyde in PBS was gently added and the plates left to fix at RT for 16 hours. The fixed plates were washed twice with H20 and rapidly dried with a hairdryer. The plates could then be inspected under the microscope. For photography, the plates were subsequently stained with 1% wt/vol Naphthol BlueBlack (Sigma N3005) in 7.5% HAC for 2 hours, washed three times with 7.5% HAC, and once with H20, and dried rapidly with a hair drier.
Analysis of RBCs adherent to plastic coated with anti-CD36 MoAbs. Using the above protocol, entire 3 cm bacteriologic petri dishes (Falcon no. 1007) were coated with 3 mL 10 pg/mL Rb anti-Mu IgG (Fc specific), followed by 3 mL 8A6 hybridoma supernatant, TS2/9 hybridoma supernatant, or 10 kg/mL dilutions of purified 8A6 or purified 0-5.
The washed plates were incubated for 45 minutes at 37°C with 3 mL RBC suspension in RPMI 1640 containing 10% FCS and 25 mmol/L HEPES, then washed with the same medium until only adherent cells remained, as seen microscopically. The adherent cells were resuspended by vigorous pipetting close to the plate surface and collected in two washes with medium. The washed plates were inspected microscopically for removal of cells. Eluted cells were then stained for reticulocytes using Brilliant Cresyl Blue followed by Wright's stain (both from Sigma). Ten thousand cells were counted to determine the percentage of reticulocytes in each sample.
Adherence of RBCs to antibody immobilized on plastic.

RESULTS
FACS analysis of normal human
RBCs with anti-CD36 and control MoAbs. We could consistently detect a CD36-like antigen on RBCs by FACS analysis. Normal RBCs were stained with eight different FITC-and R-PE-labeled reagents in secondary and tertiary combinations and analyzed by FACScan. All reagents gave weak positive staining with purified 8A6, O M , and OKM8 as primary antibody, but were negative with 1B1, 1D3, and MOPC21 (results for stain 6 shown in Fig 1) . Two reagents (stain 1 and stain 5) were relatively insensitive compared with the other six, which gave comparable levels of staining. The six sensitive reagents shifted the mean fluorescence of the RBCs by a factor of 1.5 to 3 depending on the anti-CD36 MoAb and the secondary reagent, whereas the control MoAbs remained within 10% of the control without primary MoAb ( Table 1 ). The SA6 hybridoma supernatant was also clearly positive (Table l) , staining RBCs, C32 cells, and U937 cells at a level shown in titrations to be consistent with the low MoAb concentration (0.2 p,g/mL) in this supernatant (data not shown). Upon staining of RBCs with anti-CD36 MoAbs, the overall shape of the fluorescence histograms remained similar to the unstained cells, suggesting that a high percentage of cells is positive (Fig 1) . This percentage could not be determined exactly because the histograms of the stained cells still overlapped with the unstained cells at this level of fluorescence. A minimum estimate of the proportion of cells that are positive was obtained by subtracting the histograms of cells stained only with secondary and tertiary reagents from the histograms obtained when primary antibody was included (see Materials and Methods). Thirty percent to 60% of the cells scored positive by this criterion (Table 1) . Control MoAbs showed at most 10% positivity, and usually had cells in the subtracted plot ranging over the entire fluorescence range of the histogram rather than being concentrated at the higher fluorescence levels, as with the anti-CD36 MoAbs. With the antiglycophorin MoAb, the dilution of hybridoma supernatant used in Fig 1 was chosen to be high enough (1,000-fold) so as to obtain histograms within the measurable range of fluorescence; at higher concentrations of MoAb, both antiglycophorin MoAbs gave relative mean fluorescence greater than 2,000 times the levels in the absence of primary MoAb (data not shown). RBCs from six different normal donors gave similar results (data not shown). Cell samples sorted with several different forward and side scatter gate settings gave similar results. Similar results were obtained whether the buffer contained 1 mg/mL BSA or 2% FCS, and 0 or 2 mmol/L EDTA.
To evaluate whether fragments of leukocytes and especially platelets might adhere to the RBCs and be responsible for the apparent expression of CD36 on RBCs, we tested RBCs with several other antileukocyte MoAbs: MoAb CL203, which reacts with ICAh4-1, which is expressed on activated B cells and on peripheral blood monocytes; MoAb 4H9, which reacts with CD7 expressed on peripheral T cells; MoAb 7F12, which reacts with CD61, which is expressed on platelets and peripheral blood monocytes; and MoAb L133
Comparative FACS analysis of RBCs and platelets.
For 
'
reactive with CD31, which is expressed on platelets, peripheral blood granulocytes, monocytes, and T cells. All four MoAbs were negative with RBCs (Fig 1 and Table 1 ). With platelets, MoAb 7F12 and MoAb L133 were strongly positive (Fig 2) , as were anti-CD36 MoAbs 8A6, OKM5, and OKM8. 1B1 and 1D3 gave 10-to 20-fold lower staining relative to 8A6, OKM5, and OKM8. MoAb 7F12 stained platelets more strongly than the anti-CD36 MoAbs (Fig 2) , but was negative with RBCs (Fig 1) .
Comparative FACS analysis of RBCs with MoAbs against other RBCs and eythroid-lineage antigens. RBCs were tested with MoAbs 44D and 543 against CR1 and MoAb TS2/9 against LFA-3. All three MoAbs reacted more strongly with RBCs than the anti-CD36 MoAbs (Table 1) . FACS analysis of samples stained with a range of dilutions of these MoAbs showed that the levels of staining obtained with the anti-CR1 and anti-LFA-3 MoAbs when used at 10 pg/mL purified MoAb or 50 pL hybridoma supernatant, were saturating (data not shown). Binding of purified 8A6 and OKM5 was also shown to be saturating (data not shown). RBCs were also tested with MoAbs LO1.l and W6/32, neither of which gave appreciable staining with stain 6 (Table 1) .
Absorption of 8A6 and OKM5 MoAbs by cells bearing CD36. Titration of CHO-CD36 and RBCs using mean fluorescence or percent positive RBCs as the titration parameter measured showed that staining only becomes sensitive to MoAb concentration when the MoAb concentration falls below 1 pg/mL, ie, when more than 80% of added MoAb has been absorbed (data not shown). With 8A6 purified from ascites, a single absorption with CHO-CD36 cells was sufficient to remove greater than 99.5% of reactivity with either CHO-CD36 cells or RBCs, and two absorptions removed almost all activity (Fig 3) . All detectable OKM5 reactivity was absorbed from solution in a single absorption with CHO-CD36 (data not shown). CHO cells were negative with both MoAbs (data not shown), and MoAb solutions absorbed with three successive aliquots of CHO cells still showed the same level of staining with both CHO-CD36 cells and RBCs as the original 5 pg/mL MoAb dilution (Fig 3 and data not shown) . Absorption with three successive aliquots of RBCs also did not remove a detectable fraction of the anti-CD36 reactivity (Fig 3) . For comparison, we also tested a sample of a commercially available mouse MoAb purified from ascites on protein A-Sepharose, which was found to be contaminated with antiblood group reactivity such that it agglutinated RBCs and stained them at a level of 270-fold autofluorescence (data not shown). In this instance, absorption of this antibody with a single aliquot of RBCs was sufficient to remove almost all antiblood group reactivity (data not shown).
RBCs from patient 425 failed to stain with MoAb 8A6 (purified or hybridoma supernatant) or OKM5 (Fig 4) . In t-tests, the difference between the means of percent RBCs positive
Analysis of RBCsfrom Gambianpatient 425.
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From Leukocyte-depleted normal O+ RBCs from four different donors were stained with the above primary antibodies and R-PE-labeled F(ab')r of Go anti-Mu IgG Fc (stain 6 in Materials and Methods). Antibodies used as purified MoAb originating from ascites are suffixed p. These were used at 10 Fg/mL. Antibodies used as hybridoma supernatant are suffixed s. with normal RBCs versus GAM425 RBCs when staining with 8A6 hybridoma supernatant, purified 8A6, or OKM5 were significant at the 1% level for each antibody. Although staining of GAM425 RBCs with these MoAbs is close to that of the negative controls, our data cannot distinguish between lack of CD36 on GAM425 RBC or a fourfold decrease in the level of expression, given that the level of expression on normal RBCs is already low.
Adhesion of RBCs to anti-CD36 MoAb-coated plastic. Expression of CD36 epitopes on RBCs was also detected using anti-CD36 MoAbs immobilized on plastic. Similar results were obtained whether purified MoAbs were spotted directly on plastic (data not shown), or using a coating of protein A (Fig 5) or Rb anti-Mu IgG (data not shown) to bind MoAbs to the plate. All three MoAbs capable of reversing rosettes (OKM5,OKh48, and 8A6, all three of the IgGl subclass) mediated adherence of RBCs to plastic. RBCs did not adhere to plastic coated with either anti-CD36 MoAbs that do not bind to cell surface CD36 (1B1 and 1D3) or with IgGl myeloma protein MOPC21 (Fig 5) . Spots with protein A alone were negative and spots overlaid with antiglycophorin MoAbs were strongly positive (Fig 5) . By Brilliant Cresyl Blue and Wright's staining, the cell populations adherent to plates with anti-CD36 MoAbs were indistinguishable from the original RBCs added to the plate. The original RBCs, on counting 10 samples of 1,000 cells, contained no detectable white blood cells (WBCs) and had 1.15% reticulocytes (SD = 0.32%, n = 10). RBCs eluted from plates carrying 8A6 from hybridoma supematant, purified 8A6 from ascites, purified OKh45, or TS2/9 from hybridoma supernatant also contained no detectable WBCs and the percentages of reticulocytes were 0.95% (SD = 0.26%), 1.40% (SD = 0.47%), 1.13% (SD = 0.40%), and 1.32% (SD = 0.53%), respectively.
DISCUSSION
The presence of CD36 on adult erythrocytes has previously been discounted. Earlier studies with an anti-CD36 murine IgGl MoAb (FA6-152) did not detect any CD36 on adult RBCs, although positive reactivity was noted with a minority of adult reticulocytes. In these s t~d i e s ,~~J~ it was 
9
Relative Fluorescenceconcluded that CD36 is a marker of early erythroid differentiation because FA6-152 reacted with erythroblasts generated from adult or fetal progenitors and with fetal erythrocytes. MoAb FA6-152 failed to identify CD36 on adult RBCs by antibody-mediated cell agglutination, immunofluorescence microscopy, or immunoprecipitation of radiolabeled RBC glycoprotein^.^,^^ In addition, RBCs were reported as essentially negative with 5 anti-CD36 MoAbs in the Leukocyte Typing Workshop IV.3O We were similarly unable to detect CD36 on RBCs by agglutination and immunofluorescence microscopy (S.M. Handunnetti, unpublished results). However, using FACS analysis, we were consistently able to identify CD36 antigenic activity on RBCs from all six normal donors tested. For the rest of the discussion we will refer to this antigen as CD36 for brevity, while remaining aware that the antigen may be a different form of CD36 than that present on other cell types. For instance, the form of CD36 on fetal erythroblasts and fetal mature erythrocytes is 78 Kd, whereas adult platelet CD36 is 88 Kd.29
The level of CD36 we were able to detect by FACS analysis is clearly very low and close to the limits of detection. To confirm that staining is due to expression of CD36 on RBCs, we tested two possible artifactual causes of staining with anti-CD36 MoAbs. First, the possibility that fragments of platelets became adherent to RBCs during processing of blood was tested by FACScan analysis with antiplatelet MoAbs 7F12 and L133. Both MoAbs were negative with RBCs, even though with platelets these MoAbs stain similarly or more strongly than the anti-CD36 MoAbs (Fig 2) . Thus, the staining of RBCs with anti-CD36 MoAbs cannot be accounted for by any adherence of platelet fragments. Second, ascites of some individual mice may contain small amounts of normal mouse Ig with antihuman RBC reactivity, some of which will copurify on protein A-Sepharose. We therefore tested by an absorption experiment (Fig 3) whether the reactivity of the anti-CD36 MoAbs was specific to CD36 or might represent low levels of antihuman RBC normal mouse Ig. We found that absorption of 8A6 and OKh45 MoAb solutions with CHO-CD36 completely removed the reactivity with RBCs, whereas absorption with CHO cells or RBCs had no effect. In addition, we found that a hybridoma supernatant of 8A6 was positive with RBCs (Table 1) . We conclude that staining of RBCs with anti-CD36 MoAbs is specific for CD36.
Transferrin receptor and HLA-A,B,C, like CD36,28,29 are present on erythroblasts and at low levels on some reticuloc y t e~.~~,~~ In addition, low levels of HLA-A,B,C have been reported to be present on mature RBCs of some normal don0rs,3',~~ using the W6/32 MoAb as the detecting antibody.38 With MoAbs W6132 and M1.l and stain 6, we could detect little or no expression of either HLA-A,B,C or transferrin receptor on the RBCs of the donors we tested ( Table 1 ). The use of a single MoAb to test the presence of these antigens is subject to the limitation that the antigens might still be present in a tissue-specific form lacking reactivity with the test MoAb. Subject to this limitation, our data would suggest that the retention of CD36 on mature erythrocytes may be relatively specific and may indicate a biologic role for this molecule on RBCs in the normal individual.
The enhancement of relative mean fluorescence we obtained with anti-CD36 antibodies was approximately a factor of 2, ie, the fluorescence due to R-PE-labeled antibody bound is approximately equal to the autofluorescence of the cells (Table 1) . We also determined the mean fluorescence obtained with antibodies for which the number of sites per cell is well-characterized: LFA-3, 4,000 m o l e c u l e s /~e l l~~~~~; CR1, which shows allelic variation in the amount expressed, with a population average of 600 molecules per ~e l l~l -~~; and glycophorin A, 1,000,000 molecules of glycophorin per ell.^,^^ The fluorescence with anti-LFA-3 antibodies was 84-fold autofluorescence, and the fluorescence with anti-CR1 MoAbs was 9-to 18-fold autofluorescence (Table 1) . Staining with antiglycophorin A antibodies was capable of giving enhancements of more than 2,000-fold, the maximum level of staining being off-scale on the instrument (data not shown). Although accurate quantitation of the amount of CD36 on RBCs will require detailed studies with multiple 1251-labeled MoAbs and Fab our data with anti-CR1, anti-LFA-3, and antiglycophorin MoAbs consistently suggest that the number of CD36 molecules per cell is below 500.
The plate adherence assay (Fig 5) and its lack of selectivity for reticulocytes suggest that, although the amount of CD36 expressed on RBCs is low as detected by FACS analysis, there are enough CD36-like molecules on the surface of normal RBCs to mediate adherence to a surface presenting suitable receptors, such as anti-CD36 MoAbs in this assay. It is also possible that CD36 on RBCs may act together with other receptors in mediating adhesion phenomena, because many cell adhesion phenomena involve multiple receptor^?,^^,^^ With respect to the adhesion of P falciparum-infected cells to uninfected erythrocytes, it is interesting to note that ICAM-1, which has been identified as an additional adherence receptor on endothelial cells for some isolates of P falcipai~m,23,~8 could not be detected on RBCs with the CL203 MoAb ( cannot be ruled out that there might be alternative form of ICAM-1 on RBCs that does not react with this MoAb, or that molecules present at levels undetectable by this assay could still be involved in adhesion.
The expression of CD36 is thought to decrease as the erythroblast matures to reticulocyte and mature erythrocyte.ZR.2Y The results we obtained suggest that, among circulating erythrocytes in a normal individual, the level of CD36 remains relatively constant as the erythrocyte ages, because the fluorescence histograms (Fig 1) RBC, 49 it might be interesting to investigate its possible role in clearance and degradation of TSP. CD36 on RBCs might also be involved in adhesion phenomena involving TSP or collagen. Erythroid progenitor cells at the burst-forming unit-erythroid (BFU-E) or colonyforming unit-erythroid (CFU-E) stage have been shown to attach to TSP,sn but studies so far have not been able to detect RBC adhesion to TSP-coated plastieS" (van Schravendijk, unpublished results). The low levels of CD36 present may control adhesion of RBCs, so that adhesion to cells or matrix carrying TSP might only be seen in the presence of synergistic interactions with other receptors, or with a high density or aggregated form of TSP. A possible analogy might be the situation with von Willebrand factor (vWF), which mediates RBC adhesion to endothelial cells when multimeric forms of vWF are induced with desmopressin.5' Alternatively, the level of negative surface charge on RBCs and other cells may be critical in controlling adhesion. For instance, the ability of LFA-3 and CD2 to mediate rosetting of human RBCs specifically with activated T cells, rather than resting T cells, is thought to be controlled by a change in surface charge on T-cell a c t i v a t i~n .~.~~ Finally, it remains to be seen whether the signal transduction properties of CD3612-1s are relevant to CD36 on RBCs. It has been postulated that cell-cell interactions between erythrocytes and platelets enhance platelet reactivityS3qs4 and may activate erythrocytes to release ADP.s4
Three percent to 11% of phenotypically normal Japanese individuals and 0.34% of normal United States donors lack detectable platelet CD36.2n These Naka-individuals have no overt hemostatic problems and were identified by screening healthy blood donors. Recently, it has been shown that CD36 is also missing from monocytes of these individuals, and that PRBCs of the Itg strain of P falcipamm did not adhere to Nak"-platelets and monocytes. 21 We identified here a Gambian patient with P falcipamm maFor personal use only. on October 3, 2017. by guest www.bloodjournal.org From CD36 ON ERYTHROCYTES 2113 laria (patient 425), who was deficient in the expression of CD36 on erythrocytes. We have no information as to whether this deficiency was transient or permanent. We have shown29a that the P falcipamm strain present in this patient was dependent on CD36 for rosetting and did not rosette with the patient's own RBCs. In this way, some African patients may be protected from rosetting of CD36-dependent strains of P falcipamm. The frequency and etiology of the CD36-deficient RBC phenotype in African populations remains to be determined, as does any correlation with the clinical picture of malaria in these patients. Furthermore, if such individuals are deficient in CD36 on all cell types, the course of malaria in these individuals could give important information about the importance of CD36 in sequestration in vivo in humans. The ability to bind to CD36 is the most widely distributed cytoadherence property among wild isolates of P falcipamm, 22,23 and this is thought to reflect the importance of CD36 for PRBC sequestration via adherence to endothelial cells in the microvasculature. If individuals lacking CD36 were to be found to have normal susceptibility to CD36-dependent strains of malaria and normal infected cell sequestration, our understanding of the molecular basis of cytoadherence in malaria would need to be profoundly changed.
